New Key Statistics Module, Z-Score and F-Score
NAS:SUPN Key Ratios
Market Cap $ M | 2,084.53 |
Enterprise Value $ M | 1,553.26 |
P/E(ttm) | 35.31 |
PE Ratio without NRI | 29.84 |
Forward PE Ratio | 18.81 |
Price/Book | 2.07 |
Price/Sales | 2.94 |
Price/Free Cash Flow | 11.19 |
Price/Owner Earnings | 16.72 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 651.00 |
EPS (TTM) $ | 1.07 |
Beneish M-Score | -2.87 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -12.10 |
y-y EBITDA Growth Rate % | 33.70 |
EV-to-EBIT | 21.43 |
EV-to-EBITDA | 9.97 |
PEG | -- |
Shares Outstanding M | 55.22 |
Net Margin (%) | 9.16 |
Operating Margin % | 11.16 |
Pre-tax Margin (%) | 11.12 |
Quick Ratio | 1.98 |
Current Ratio | 2.20 |
ROA % (ttm) | 4.58 |
ROE % (ttm) | 6.32 |
ROIC % (ttm) | 7.13 |
Dividend Yield % | -- |
Altman Z-Score | 4.97 |
SUPN Number of Guru Trades
SUPN Volume of Guru Trades
Gurus Latest Trades with NAS:SUPN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SUPN is held by these investors
Total 4
Supernus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SUPN
Total 0- 1